We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.3B
AUM Growth
+$2.76B
Cap. Flow
+$1.92B
Cap. Flow %
12.55%
Top 10 Hldgs %
45.98%
Holding
1,005
New
144
Increased
321
Reduced
458
Closed
80

Sector Composition

Rank Sector Weight
1 Energy 54.25%
2 Financials 6.56%
3 Healthcare 3.56%
4 Consumer Discretionary 2.58%
5 Industrials 2.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCSH icon
151
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$6.25M 0.04%
79,967
-3,307
-4% -$258K
AUY
152
DELISTED
Yamana Gold, Inc.
AUY
$6.24M 0.04%
2,153,170
+140,191
+7% +$408K
META icon
153
Meta Platforms (Facebook)
META
$1.51T
$6.22M 0.04%
32,017
+786
+3% +$142K
OGE icon
154
OGE Energy
OGE
$10.3B
$6.2M 0.04%
176,057
-15,168
-8% -$510K
TRGP icon
155
Targa Resources
TRGP
$60.4B
$6.08M 0.04%
122,820
-4,866
-4% -$231K
SEMG
156
DELISTED
SEMGROUP CORPORATION
SEMG
$6M 0.04%
236,227
-20,581
-8% -$504K
ET icon
157
Energy Transfer Partners
ET
$70.1B
$5.97M 0.04%
345,915
+4,651
+1% +$76.4K
TAHO
158
DELISTED
Tahoe Resources Inc
TAHO
$5.93M 0.04%
1,205,845
-98,040
-8% -$494K
BIP icon
159
Brookfield Infrastructure Partners
BIP
$18.8B
$5.85M 0.04%
255,835
-40,388
-14% -$948K
HCM icon
160
HUTCHMED
HCM
$1.89B
$5.79M 0.04%
+191,933
New +$6.1M
MDGL icon
161
Madrigal Pharmaceuticals
MDGL
$12.6B
$5.76M 0.04%
20,579
+1,800
+10% +$316K
IMMU
162
DELISTED
Immunomedics Inc
IMMU
$5.72M 0.04%
241,871
+19,518
+9% +$392K
BTG icon
163
B2Gold
BTG
$5.16B
$5.72M 0.04%
2,217,123
+602,987
+37% +$1.65M
CNNE icon
164
Cannae Holdings
CNNE
$647M
$5.72M 0.04%
308,250
+7,200
+2% +$144K
LSXMA
165
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$5.7M 0.04%
175,163
+33,786
+24% +$1.07M
SAND
166
DELISTED
Sandstorm Gold
SAND
$5.61M 0.04%
1,247,365
-881,657
-41% -$4.06M
KGC icon
167
Kinross Gold
KGC
$28.5B
$5.5M 0.04%
1,461,381
-66,765
-4% -$251K
ARRY
168
DELISTED
Array Biopharma Inc
ARRY
$5.1M 0.03%
304,200
+25,712
+9% +$409K
GWPH
169
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.1M 0.03%
36,523
+2,583
+8% +$367K
SUPN icon
170
Supernus Pharmaceuticals
SUPN
$2.68B
$5.09M 0.03%
84,996
+5,167
+6% +$268K
HMY icon
171
Harmony Gold Mining
HMY
$9.92B
$4.92M 0.03%
3,152,799
-640,538
-17% -$1.2M
LTC
172
LTC Properties
LTC
$2.16B
$4.79M 0.03%
+112,000
New +$4.39M
CG icon
173
Carlyle Group
CG
$16.3B
$4.76M 0.03%
223,339
-101,015
-31% -$2.17M
ENDP
174
DELISTED
Endo International plc
ENDP
$4.73M 0.03%
501,708
+43,791
+10% +$294K
NGD
175
DELISTED
New Gold Inc
NGD
$4.65M 0.03%
2,235,191
-304,974
-12% -$705K

Similar funds

ALPS Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, ALPS Advisors held 1,005 positions worth $15.3B, up 22% from $12.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

ALPS Advisors deployed $1.92B of net new capital in Q2 2018, opening 144 new positions and adding to 321 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,144 shares worth $323M.

By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 56% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy Midstream Ptr LP, an estimated $55.1M trimmed.

  • ALPS Advisors's largest Q2 2018 buy was Berkshire Hathaway Class A: 1,144 shares worth $323M.
  • ALPS Advisors added most to JPMorgan Chase in Q2 2018, an estimated $113M increase.
  • ALPS Advisors's biggest Q2 2018 reduction was Dominion Energy Midstream Ptr LP, cutting an estimated $55.1M.
  • ALPS Advisors fully exited BeOne Medicines Ltd in Q2 2018, selling an estimated $9.35M.
  • ALPS Advisors's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2018.
  • ALPS Advisors opened 144 new positions and closed 80 in Q2 2018.
  • ALPS Advisors's portfolio value rose 22% quarter-over-quarter to $15.3B.

Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.